Transparency tools in gene patenting for informing policy and practice

Nature Biotechnology,  December 06, 2013

The Supreme Court’s decision in Myriad highlights the need for tools enabling nuanced and precise analysis of gene patents at the global level. The decision underscores a pressing need for precise analysis of patents that disclose and reference genetic sequences, especially in the claims. Similarly, data sets, standards compliance and analytical tools must be improved— in particular, data sets and analytical tools must be made openly accessible— in order to provide a basis for effective decision making and policy setting to support
biological innovation.


Comments (0)